Endomag

Endomag, a Hologic company based in Cambridge, United Kingdom, is a medical technology firm focused on improving breast cancer care. Founded in 2007 from research at University College London and the University of Houston, Endomag has established itself as a leader in the field. The company was acquired by Hologic in 2024, enhancing its ability to innovate in women's health. Endomag's mission centers on preventing unnecessary surgeries, improving surgical outcomes, and enhancing the patient experience. The company offers a range of products, including the Magseed Marker for tumor localization, the Magtrace Lymphatic Tracing Injectable for cancer staging, and the Sentimag Platform, which integrates localization and lymphatic tracing. These technologies are used in over 1,350 hospitals across more than 45 countries, benefiting over 500,000 women with more precise and less invasive treatment options.

Medical Devices Milton, United Kingdom ~10 employees

Work at Endomag in HR or recruiting? Claim this page

Employees
10
0% in the 3 months to Sep 2026
Revenue / employee
$3.5M
Revenue ~$35M
12-month attrition
35.1%
Tech: 16.7%
H1B sponsor
NA

Headcount trend

Endomag went from 21 employees in Oct 2024 to 10 in Sep 2026.

Org structure

Headcount by department

Sales4
Other3
Engineering1
Product1
Success1

Endomag FAQ

How many employees does Endomag have?

Endomag has about 10 employees, unchanged over the 3 months to Sep 2026.

What is Endomag's revenue per employee?

Endomag makes about $3.5M in revenue per employee, based on $35M annual revenue and 10 employees.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.